This Wiki is currently under construction
For the complete documentation index, see llms.txt. This page is also available as Markdown.

why thiamine matters

Section: Thiamine Fundamentals Reading level: Introductory Last reviewed: October 2026

In brief

Every cell needs energy, and thiamine is required at several key steps where the body turns food into that energy. When thiamine runs short, the organs that use the most energy are hit first: the brain, the nerves and the heart.

Severe deficiency causes well-recognised and potentially fatal diseases: beriberi and Wernicke encephalopathy. These are preventable and, if caught early, often treatable. They still occur today, including in wealthy countries, and they are frequently missed.

Key points

  • Thiamine is needed to release energy from glucose and from some amino acids.

  • The brain is especially dependent on it, because the brain runs mainly on glucose and uses about a fifth of the body's resting energy.

  • Severe deficiency can damage the nervous system (dry beriberi, Wernicke encephalopathy, Korsakoff syndrome) and the heart (wet beriberi).

  • Deficiency is not just historical. It occurs in alcohol use disorder, after bariatric surgery, with persistent vomiting, in critical illness, and in infants in some parts of the world.

  • Autopsy studies show that Wernicke encephalopathy is often not diagnosed during life.

  • Research into thiamine's role in common chronic conditions is active but largely unsettled.

The energy connection

A useful way to picture thiamine is as a gatekeeper at metabolic junctions. Food is broken down step by step. At certain points, a molecule has to pass through an enzyme that only works when its thiamine-based helper, thiamine pyrophosphate (TPP), is present.

The most important of these gates sits between two major stages of energy production:

  1. Glycolysis, which splits glucose into pyruvate and yields a small amount of energy.

  2. The Krebs cycle and oxidative phosphorylation in mitochondria, which yield most of the cell's energy.

Without enough TPP, pyruvate cannot pass efficiently into the mitochondria. Cells then produce much less energy and accumulate lactate instead. This is why lactic acidosis can be a sign of severe deficiency.

For the full picture of how this works, see How the Body Uses Thiamine.

The organs most at risk

Organ or system
Why it is vulnerable
What deficiency can cause

Brain

High, constant energy demand; relies mainly on glucose

Confusion, impaired memory, problems with balance and eye movements (Wernicke encephalopathy); lasting memory loss (Korsakoff syndrome)

Peripheral nerves

Long nerve fibres need a continuous energy supply

Numbness, tingling, burning, weakness, mainly in the legs (dry beriberi)

Heart and blood vessels

Heart muscle works continuously

Fast heart rate, breathlessness, fluid retention, heart failure (wet beriberi)

Digestive system

Smooth muscle and gut lining have high turnover and energy needs

Nausea, abdominal pain, vomiting (described as gastrointestinal beriberi)

Autonomic nervous system

Controls heart rate, blood pressure, digestion and sweating

Dizziness on standing, abnormal sweating and other autonomic symptoms (described in beriberi)

Diseases caused by deficiency

Condition
What it is

Dry beriberi

Nerve damage (peripheral neuropathy), mainly affecting the legs

Wet beriberi

Heart involvement with fluid retention and heart failure

Shoshin beriberi

A rapid, severe form of wet beriberi with lactic acidosis and circulatory collapse; a medical emergency

Wernicke encephalopathy

Acute brain dysfunction; a medical emergency

Korsakoff syndrome

Severe, often lasting memory impairment, usually after Wernicke encephalopathy

Infantile beriberi

Occurs in breastfed infants of thiamine-deficient mothers; can be rapidly fatal

These conditions are covered in detail in the Health Conditions section. Symptoms are summarised in Symptoms of Low Thiamine.

Not a disease of the past

Fortification greatly reduced beriberi in many countries, but thiamine deficiency persists. Examples include:

  • Alcohol use disorder, the most common setting in high-income countries.

  • Bariatric (weight-loss) surgery, especially when complicated by vomiting.

  • Hyperemesis gravidarum (severe vomiting in pregnancy).

  • Eating disorders, prolonged fasting and malnutrition.

  • Critical illness, refeeding after starvation, and long-term intravenous nutrition without adequate vitamins.

  • Infants in parts of South and Southeast Asia, where diets rely heavily on polished rice and maternal intake is low.

  • Humanitarian settings, such as refugee camps dependent on limited food rations.

A striking modern example occurred in Israel in 2003, when a soy-based infant formula was found to contain almost no thiamine. Infants developed severe deficiency; several died and others were left with lasting neurological problems.

Why it is easily missed

In a landmark autopsy study of 131 people with brain changes of Wernicke encephalopathy, only about one in five had been diagnosed during life. Many did not show the full "textbook" set of symptoms.

Reasons deficiency is missed include:

  • Early symptoms such as fatigue, irritability and poor appetite are non-specific.

  • The classic signs often appear incompletely.

  • Blood tests have limitations and are not always available quickly (see Testing Limitations).

  • It is often not considered outside the setting of heavy alcohol use.

Areas of active research

Beyond classic deficiency disease, researchers are investigating whether thiamine status plays a role in more common conditions. The research is at very different stages in each area.

Area
What has been reported

Diabetes

Low plasma thiamine is common in people with diabetes, linked to increased loss through the kidneys

Heart failure with diuretic use

Loop diuretics such as furosemide increase urinary thiamine loss

Critical illness and sepsis

Deficiency is common in intensive care; trials of thiamine in septic shock have shown mixed results

Neurodegenerative disease

Reduced activity of thiamine-dependent enzymes in Alzheimer's disease brains; small trials of derivatives such as benfotiamine

Fatigue

A small randomised controlled trial in inflammatory bowel disease reported reduced fatigue with high-dose oral thiamine

Functional disorders (e.g. dysautonomia, ME/CFS)

Proposed mechanisms and case reports

Open questions

  • How common mild or "subclinical" deficiency is in the general population, and whether it has health effects.

  • Whether thiamine supplementation improves outcomes in diabetes, heart failure, sepsis or neurodegenerative disease.

  • Whether blood tests reflect thiamine status in the brain and other tissues.

  • What Is Thiamine?

  • How the Body Uses Thiamine

  • Symptoms of Low Thiamine

  • Causes of Deficiency

  • Common Misconceptions

References

  1. Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. Journal of Neurology, Neurosurgery & Psychiatry. 1986;49(4):341–345.

  2. Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurology. 2007;6(5):442–455.

  3. Whitfield KC, et al. Thiamine deficiency disorders: diagnosis, prevalence, and a roadmap for global control programs. Annals of the New York Academy of Sciences. 2018;1430(1):3–43.

  4. Smith TJ, et al. Thiamine deficiency disorders: a clinical perspective. Annals of the New York Academy of Sciences. 2021;1498(1):9–28.

  5. Fattal-Valevski A, et al. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula. Pediatrics. 2005;115(2):e233–e238.

  6. Thornalley PJ, et al. High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia. 2007;50(10):2164–2170.

  7. Seligmann H, et al. Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study. American Journal of Medicine. 1991;91(2):151–155.

  8. Donnino MW, et al. Randomized, double-blind, placebo-controlled trial of thiamine as a metabolic resuscitator in septic shock: a pilot study. Critical Care Medicine. 2016;44(2):360–367.

  9. Bager P, et al. Randomised clinical trial: high-dose oral thiamine versus placebo for chronic fatigue in patients with quiescent inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 2021;53(1):79–86.

  10. Gibson GE, et al. Benfotiamine and cognitive decline in Alzheimer's disease: results of a randomized placebo-controlled phase IIa clinical trial. Journal of Alzheimer's Disease. 2020;78(3):989–1010.

Editorial note: This page describes mechanisms and published evidence. It is not medical advice and does not recommend doses. Suggest corrections or new sources via the feedback link.

Was this helpful?